Picton Mahoney Asset Management lifted its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 164,061.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,341 shares of the health services provider's stock after purchasing an additional 21,328 shares during the period. Picton Mahoney Asset Management's holdings in Maximus were worth $1,456,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. UMB Bank n.a. boosted its position in Maximus by 70.2% during the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after purchasing an additional 250 shares during the last quarter. GAMMA Investing LLC boosted its position in Maximus by 67.1% during the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after purchasing an additional 294 shares during the last quarter. NBC Securities Inc. boosted its position in Maximus by 114,900.0% during the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock valued at $78,000 after purchasing an additional 1,149 shares during the last quarter. Blue Trust Inc. boosted its position in Maximus by 32.8% during the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after purchasing an additional 303 shares during the last quarter. Finally, LRI Investments LLC boosted its position in Maximus by 44.1% during the fourth quarter. LRI Investments LLC now owns 1,638 shares of the health services provider's stock valued at $122,000 after purchasing an additional 501 shares during the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Maximus
In other news, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the sale, the director directly owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. This represents a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.60% of the company's stock.
Maximus Stock Down 1.4%
NYSE MMS traded down $1.02 during trading on Friday, hitting $72.84. 509,770 shares of the company traded hands, compared to its average volume of 422,065. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.94. The business has a fifty day simple moving average of $71.31 and a 200 day simple moving average of $70.55. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.87. The company has a market capitalization of $4.10 billion, a P/E ratio of 14.48 and a beta of 0.61.
Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.64. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The business's revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company earned $1.57 earnings per share. As a group, sell-side analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.
Maximus Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, August 15th. Maximus's dividend payout ratio is currently 23.86%.
Analysts Set New Price Targets
Separately, Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.
Check Out Our Latest Stock Report on Maximus
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.